DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Mathis M V, Muoio BM, Andreason P. et al.
The US Food and Drug Administrationʼs perspective on the new antipsychotic pimavanserin.
J Clin Psychiat 2017;
78: 668-673
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.